# Martin Goroško

> Martin Goroško is a seed investor in Tallinn backing FinTech, Medical and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: Tallinn, Estonia
- Total investments: 3
- Last investment: Jun 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/martingorosko
- Website: https://x.com/martingorosko

Martin Goroško is a seed investor in Tallinn focused on FinTech and Medical. Martin Goroško

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 1 | 33% |
| Medical | 1 | 33% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |
| Mobile Payments | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Funding Round | 1 | 33% |
| Convertible Note | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nanordica Medical | Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $1.8M | Venture - Series Unknown | Jun 09, 2026 |  |
| Cino | Cino is a mobile app that enables group payments with seamless, real-time bill splitting. | $550K | Convertible Note | May 26, 2023 |  |
| Nanordica Medical | Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $402.7K | Seed | Jan 10, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [2C Ventures](https://shizune.co/investors/profile/2c-ventures) — VC Fund, 1 deal together
- [Amalfi](https://shizune.co/investors/profile/amalfi-0522) — VC Fund, 1 deal together
- [Health Founders](https://shizune.co/investors/profile/health-founders-8d85) — VC Fund, 1 deal together
- [Superangel](https://shizune.co/investors/profile/superangel) — VC Fund, 1 deal together
- [Specialist VC](https://shizune.co/investors/profile/united-angels-vc) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Specialist VC](https://shizune.co/investors/profile/united-angels-vc) — VC Fund
- [Superangel](https://shizune.co/investors/profile/superangel) — VC Fund
- [Tera Ventures](https://shizune.co/investors/profile/tera-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in Estonia](https://shizune.co/investors/medical-investors-estonia)

## FAQ

### What does Martin Goroško invest in?

Martin Goroško invests primarily in FinTech, Medical and Software startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Estonia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Martin Goroško last invest?

The most recent investment recorded for Martin Goroško closed in Jun 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co